359 related articles for article (PubMed ID: 33918664)
1. Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis.
Gacem N; Nait-Oumesmar B
Life (Basel); 2021 Apr; 11(4):. PubMed ID: 33918664
[TBL] [Abstract][Full Text] [Related]
2. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases.
Skaper SD
Prog Brain Res; 2019; 245():119-144. PubMed ID: 30961866
[TBL] [Abstract][Full Text] [Related]
3. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
4. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
Dulamea AO
Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
[TBL] [Abstract][Full Text] [Related]
5. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
6. MiR-146a promotes oligodendrocyte progenitor cell differentiation and enhances remyelination in a model of experimental autoimmune encephalomyelitis.
Zhang J; Zhang ZG; Lu M; Zhang Y; Shang X; Chopp M
Neurobiol Dis; 2019 May; 125():154-162. PubMed ID: 30707940
[TBL] [Abstract][Full Text] [Related]
7. The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies.
Dulamea AO
Neural Regen Res; 2017 Dec; 12(12):1939-1944. PubMed ID: 29323026
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases shape the oligodendrocyte (niche) during development and upon demyelination.
Gorter RP; Baron W
Neurosci Lett; 2020 Jun; 729():134980. PubMed ID: 32315713
[TBL] [Abstract][Full Text] [Related]
9. Sox2 Is Essential for Oligodendroglial Proliferation and Differentiation during Postnatal Brain Myelination and CNS Remyelination.
Zhang S; Zhu X; Gui X; Croteau C; Song L; Xu J; Wang A; Bannerman P; Guo F
J Neurosci; 2018 Feb; 38(7):1802-1820. PubMed ID: 29335358
[TBL] [Abstract][Full Text] [Related]
10. Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
[TBL] [Abstract][Full Text] [Related]
11. The committed oligodendrocyte precursor cell, a newly-defined intermediate progenitor cell type in oligodendroglial lineage.
Fang M; Chen L; Tang T; Qiu M; Xu X
Glia; 2023 Nov; 71(11):2499-2510. PubMed ID: 37278537
[TBL] [Abstract][Full Text] [Related]
12. Activation of oligodendroglial Stat3 is required for efficient remyelination.
Steelman AJ; Zhou Y; Koito H; Kim S; Payne HR; Lu QR; Li J
Neurobiol Dis; 2016 Jul; 91():336-46. PubMed ID: 27060559
[TBL] [Abstract][Full Text] [Related]
13. Conditional Deletion of the L-Type Calcium Channel Cav1.2 in NG2-Positive Cells Impairs Remyelination in Mice.
Santiago González DA; Cheli VT; Zamora NN; Lama TN; Spreuer V; Murphy GG; Paez PM
J Neurosci; 2017 Oct; 37(42):10038-10051. PubMed ID: 28899915
[TBL] [Abstract][Full Text] [Related]
14. Engineering biomaterial microenvironments to promote myelination in the central nervous system.
Unal DB; Caliari SR; Lampe KJ
Brain Res Bull; 2019 Oct; 152():159-174. PubMed ID: 31306690
[TBL] [Abstract][Full Text] [Related]
15. miRNAs As Emerging Regulators of Oligodendrocyte Development and Differentiation.
Galloway DA; Moore CS
Front Cell Dev Biol; 2016; 4():59. PubMed ID: 27379236
[TBL] [Abstract][Full Text] [Related]
16. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
17. Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions.
Pfeifenbring S; Metz I; Kremer D; Küry P; Hartung HP; Brück W
Glia; 2013 Aug; 61(8):1250-60. PubMed ID: 23828667
[TBL] [Abstract][Full Text] [Related]
18. Impaired Postnatal Myelination in a Conditional Knockout Mouse for the Ferritin Heavy Chain in Oligodendroglial Cells.
Wan R; Cheli VT; Santiago-González DA; Rosenblum SL; Wan Q; Paez PM
J Neurosci; 2020 Sep; 40(40):7609-7624. PubMed ID: 32868463
[TBL] [Abstract][Full Text] [Related]
19. Epidermal Growth Factor Pathway in the Age-Related Decline of Oligodendrocyte Regeneration.
Rivera AD; Azim K; Macchi V; Porzionato A; Butt AM; De Caro R
Front Cell Neurosci; 2022; 16():838007. PubMed ID: 35370556
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage.
Marinelli C; Bertalot T; Zusso M; Skaper SD; Giusti P
Front Cell Neurosci; 2016; 10():27. PubMed ID: 26903812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
